RVMD - What's Going On With Revolution Medicines Stock? | Benzinga
Revolution Medicines, Inc. (NASDAQ:RVMD) shares are trading higher Wednesday. The company announced the publication of several peer-reviewed research papers earlier in the week.
The Details:
Revolution Medicines announced the publication of a peer-reviewed research paper in "Cancer Discovery" detailing the discovery and preclinical to clinical translation for RMC-6236 on Monday.
The company also announced the publication of two peer-reviewed research papers in "Nature" Tuesday. The first paper highlights the discovery and preclinical characterization of RMC-7977, and the second paper highlights the systematic evaluation of RMC-7977 in a wide range of preclinical models of PDAC.
“The research summarized in our Cancer Discovery paper, combined with the preliminary RMC-6236 clinical data presented in late 2023, provide us and our investigators with the confidence to advance and expand our RMC-6236 clinical development program,” said Steve Kelsey, M.D., president, research ...